Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved multiple immune-related conditions in one patient.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

The study concludes that Traction Alopecia is often overlooked in women and children of color, and better recognition and follow-up care are needed.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Men with Addison disease should be screened for X-linked adrenoleukodystrophy if they have hair loss.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

A new method can quickly and accurately detect drugs in hair.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Some dermatology patients use traditional and complementary medicine, often for acne, and many recommend it, but they need more information about its effects.

Anionic squarticles can effectively counteract amitriptyline overdose, improving survival rates.

Alopecia areata was successfully treated with contact immunotherapy, oral antihistamines, and topical corticosteroids.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Diffuse alopecia areata causes widespread hair thinning due to an autoimmune response.

Adalimumab may cause severe hair loss in some patients.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Adults with Tatton-Brown-Rahman syndrome may have serious heart problems and need lifelong heart monitoring.